|
1
|
Shuai X, Rollins J, Moulinier I, Custis T, Edmunds M, Schilder F. A Multidimensional Investigation of the Effects of Publication Retraction on Scholarly Impact. J Assoc Inf Sci Technol 2017. [DOI: 10.1002/asi.23826] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Xin Shuai
- Research & Development Group, Thomson Reuters; 610 Opperman Dr. St. Paul MN 55123
| | - Jason Rollins
- Clarivate Analytics; 50 California St. San Francisco CA 94111
| | - Isabelle Moulinier
- Research & Development Group, Thomson Reuters; 610 Opperman Dr. St. Paul MN 55123
| | - Tonya Custis
- Research & Development Group, Thomson Reuters; 610 Opperman Dr. St. Paul MN 55123
| | - Mathilda Edmunds
- Clarivate Analytics; 1500 Spring Garden St. Philadelphia PA 19130
| | - Frank Schilder
- Research & Development Group, Thomson Reuters; 610 Opperman Dr. St. Paul MN 55123
| |
Collapse
|
|
2
|
Handley OJ, Naji JJ, Dunnett SB, Rosser AE. Pharmaceutical, cellular and genetic therapies for Huntington's disease. Clin Sci (Lond) 2005; 110:73-88. [PMID: 16336206 DOI: 10.1042/cs20050148] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
HD (Huntington's disease) is a devastating neurodegenerative disorder caused by a polyglutamine expansion in the gene encoding the huntingtin protein. Presently, there is no known cure for HD and existing symptomatic treatments are limited. However, recent advances have identified multiple pathological mechanisms involved in HD, some of which have now become the focus of therapeutic intervention. In this review, we consider progress made towards developing safe and effective pharmaceutical-, cell- and genetic-based therapies, and discuss the extent to which some of these therapies have been successfully translated into clinical trials. These new prospects offer hope for delaying and possibly halting this debilitating disease.
Collapse
Affiliation(s)
- Olivia J Handley
- The Brain Repair Group, School of Biosciences, Cardiff University, Cardiff CF10 3US, UK.
| | | | | | | |
Collapse
|